Eli Lilly Corp. buy phonebroker
Start price
06.09.20
/
50%
€128.00
Target price
04.11.21
€125.00
Performance (%)
-3.25%
End price
06.11.20
€123.84
Summary
This prediction ended on 06.11.20 with a price of €123.84. With a performance of -3.25%, the BUY prediction by phonebroker finished with a loss. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eli Lilly Corp. | -0.897% | -0.897% | 98.631% | 346.553% |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
According to phonebroker what are the pros and cons of Eli Lilly Corp. for the foreseeable future?
Pros
Future proof or reliable business model
Cons
Higher risks for its business
Risky Investment
Comments by phonebroker for this prediction
In the thread Eli Lilly Corp. diskutieren
Buy Eli Lilly Corp.
Kursziel gesetzt auf 130,0
Kursziel geändert auf 135,0
Kursziel geändert auf 125,0